Skip to main content
. 2015 Aug 21;10(8):e0136182. doi: 10.1371/journal.pone.0136182

Table 1. Overview of the demographic data.

All HF-rTMS treated patients (26 patients) Active HF-rTMS session (13 patients) Sham HF-rTMS session (13 patients) P-value
Gender (Male/Female) 17/9 9/4 8/5 ≥0.99
Age (year) Total: M = 45.2, SD = 9.3 M = 46.7, SD = 10.4 M = 43.7, SD = 8.1 0.42
Men: M = 45.1, SD = 10.5
Women: M = 45.4,SD = 6.9
Stimulation depth (mm) M = 20.5, SD = 2.5 M = 20.3, SD = 2.8 M = 20.6, SD = 2.4 0.77
Benzodiazepine free days before stimulation M = 14.3, SD = 5.6 M = 14.3, SD = 5.6 M = 10.2, SD = 3.2 0.03
% nicotine 76.9% (20 patients) 11 patients 9 patients ≥0.99
% comorbid drug dependence 15.4% (4 patients) 3 patients (2 patients: cocaine; 1 patient cannabis) 1 patient (cannabis) 0.59
% comorbid benzodiazepine dependence 7.7% (2 patients) 1 patient 1 patient 1.00
Use of anti-craving medication before stimulation (washout of 2 weeks) 2 patients 1 patient 1 patient 1.00
Baseline Alcohol Urge Questionnaire (AUQ) M = 15.9, SD = 11.0 M = 17.8, SD = 11.4 M = 14.2, SD = 10.8 0.47
Baseline 5-item Obsessive Compulsive Drinking Scale (OCDS) M = 3.8, SD = 3.8 M = 4.5, SD = 3.7 M = 3.2, SD = 4.0 0.27
Number of days patients drank more than 5 units/day (during the last month before hospitalization) (Alcohol Severity Index (ASI)) M = 19.6, SD = 9.6 M = 16.9, SD = 11.2 M = 22.5, SD = 6.8 0.17
Duration of alcohol addiction (years) (ASI) M = 12.1, SD = 9.9 M = 13.7, SD = 11.4 M = 10.3, SD = 8.1 0.41
Days between last alcohol intake and the start of the stimulation M = 17.8, SD = 6.0 M = 19.0, SD = 4.5 M = 16.5, SD = 7.2 0.31

Demographic data concerns the entire patient group. Therefore, the two patients who were not presented with the block-related cue-exposure were also considered. MT: motor threshold; M: mean; SD: standard deviation.